Cite
PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer.
MLA
Zhu, Haiying, et al. “PD-1/PD-L1 Counterattack Alliance: Multiple Strategies for Treating Triple-Negative Breast Cancer.” Drug Discovery Today, vol. 25, no. 9, Sept. 2020, pp. 1762–71. EBSCOhost, https://doi.org/10.1016/j.drudis.2020.07.006.
APA
Zhu, H., Du, C., Yuan, M., Fu, P., He, Q., Yang, B., & Cao, J. (2020). PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer. Drug Discovery Today, 25(9), 1762–1771. https://doi.org/10.1016/j.drudis.2020.07.006
Chicago
Zhu, Haiying, Chengyong Du, Meng Yuan, Peifen Fu, Qiaojun He, Bo Yang, and Ji Cao. 2020. “PD-1/PD-L1 Counterattack Alliance: Multiple Strategies for Treating Triple-Negative Breast Cancer.” Drug Discovery Today 25 (9): 1762–71. doi:10.1016/j.drudis.2020.07.006.